{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihfw3yfb2l43e7t5udfoq3w5sgtx7vpfrobni6oxx4w5v3hwglnja",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mgpyim7arpd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih2fjrw33uw362nm4o5x4rirxposhabvjq2i3bxcchmyc4o6b36i4"
    },
    "mimeType": "image/jpeg",
    "size": 1730
  },
  "path": "/story/385148/fda-scales-back-support-of-drug-for-autism-treatment.html",
  "publishedAt": "2026-03-10T12:00:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "Federal regulators are distancing themselves from earlier optimism about a cheap, decades-old drug touted as a potential breakthrough for children with autism. Per Politico , two senior FDA officials said on Monday that the agency doesn't have enough solid evidence to support leucovorin (aka folinic acid) as an autism treatment—a...",
  "title": "FDA Scales Back Support of Drug for Autism Treatment"
}